Andre-Jacques Auberton-Herve - 13 Jun 2023 Form 4 Insider Report for Bionik Laboratories Corp.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 13 Jun 2023
Net transaction value: +$331,667
SEC form: 4
Accepted by SEC: 21 Jun 2023, 10:58:48 UTC
Prior SEC filing: 21 Jun 2023
Next SEC filing: 26 Dec 2023
Source filing: View source filing
Reporting owner signature: /s/ Andre-Jacques Auberton-Herve

Key filing fact

Andre-Jacques Auberton-Herve filed Form 4 for Bionik Laboratories Corp. on 21 Jun 2023.

Key facts

This page summarizes Andre-Jacques Auberton-Herve's Form 4 filing for Bionik Laboratories Corp..
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 21 Jun 2023, 10:58.

Change

Previous filing in this sequence was filed on 21 Jun 2023.
Current net transaction value: +$331,667.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BNKL transaction

Common Stock

Conversion of derivative security

Transaction value: $111,667
Shares: +186,111
Change %: +20%
Price: $0.6000
Shares after: 1,109,271
Date: 13 Jun 2023
Ownership: Shares held through Star SCI
Footnotes: F1

BNKL holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 10,693
Date: 13 Jun 2023
Ownership: Shares held through 4A Consulting and Engineering

BNKL holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 95,149
Date: 13 Jun 2023
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BNKL transaction Derivative

Convertible Promissory Note

Purchase

Transaction value: $220,000
Shares: +1
Change %
Price: $220000.00^*
Shares after: 1
Date: 13 Jun 2023
Ownership: Through Star SCI
Underlying class: Common Stock, par value $0.001 per share
Underlying amount: 366,667
Exercise price: $0.6000
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Effective as of June 13, 2023, approximately $310,185 of principal and accrued interest of a convertible promissory note issued to Star SCI, an affiliate of the reporting person, converted in accordance with its terms into 186,111 shares of the Issuer's common stock

Footnote F2

The convertible promissory note (the "Note") will be convertible into common stock of the Issuer upon the following events on the following terms: (a) on June 1, 2024 without any action on the part of the reporting person, the outstanding principal and accrued and unpaid interest under the Note will be converted into shares of common stock at a conversion price equal to $0.60 per share; and (b) upon the consummation of the next equity or equity linked round of financing of the Issuer for cash proceeds (the "Qualified Financing"), without any action on the part of the reporting person, the outstanding principal and accrued and unpaid interest under the Note will be converted into shares of common stock at a conversion price equal to the lesser of (a) the issue price per share in the Qualified Financing and (b) $0.60 per share.